YC
AGL icon

Yarbrough Capital’s Agilon Health AGL Stock Holding History

Yarbrough Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-805
Closed -$87.2K – 153
2025
Q1 		$87.2K Sell
805
-608
-43% -$52.9K ﹤0.01% 196
2024
Q4 		$67.1K Hold
1,413
– – ﹤0.01% 189
2024
Q3 		$139K Hold
1,413
– – 0.01% 198
2024
Q2 		$231K Hold
1,413
– – 0.01% 189
2024
Q1 		$216K Hold
1,413
– – 0.01% 193
2023
Q4 		$443K Hold
1,413
– – 0.02% 146
2023
Q3 		$628K Buy
1,413
+805
+132% +$364K 0.04% 109
2023
Q2 		$264K Hold
608
– – 0.01% 186
2023
Q1 		$361K Buy
+608
New +$341K 0.03% 162

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Yarbrough Capital's AGL Position: Q2 2025 in Review

Yarbrough Capital sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 805 shares — an estimated $87.2K sold.

Yarbrough Capital first reported a position in AGL in Q1 2023 and held it in 9 quarters. The position peaked at $628K in Q3 2023. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.

  • Yarbrough Capital reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
  • Yarbrough Capital sold 805 Agilon Health shares in Q2 2025, an estimated $87.2K.
  • Yarbrough Capital first reported a position in Agilon Health in Q1 2023 and held it in 9 quarters.
  • Yarbrough Capital's Agilon Health position peaked at $628K in Q3 2023.
  • 205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.

Based on Yarbrough Capital's 13F filing for Q2 2025, filed 15 Jul 2025.